UPDATE: O’Hare Now Screening For Deadly Coronavirus; 1st U.S. Case Confirmed
The Centers for Disease Control and Prevention and the Department of Homeland Security’s Customs and Border Protection announced today (Tuesday, Jan. 21, 2020) that O’Hare has been added to the list of U.S. airports that will screen travelers in response to the outbreak of a deadly coronavirus strain.
That news comes in the wake of the first case of the virus in the U.S.
According to the CDC, a Washington state man in his 30s who returned last week from the outbreak’s epicenter, was hospitalized but is in good condition near Seattle.
The virus has infected about 300 people, all of whom had been in China, and killed six. The newly discovered virus can cause coughing, fever, breathing difficulty and pneumonia.
While originally thought to be spreading from animal-to-person, there are growing indications that limited person-to-person spread is happening. It’s unclear how easily this virus is spreading between people.
Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats. Rarely, animal coronaviruses can evolve and infect people and then spread between people such as has been seen with MERS and SARS. Past MERS and SARS outbreaks have been complex, requiring comprehensive public health responses.
According to the CDC, travelers from Wuhan to the United States will undergo entry screening for symptoms associated with the virus at five U.S. airports that receive most of the travelers from Wuhan: San Francisco, New York (JFK), Los Angeles (LAX), Atlanta and O’Hare in Chicago.
“Investigations into this novel coronavirus are ongoing and we are monitoring and responding to this evolving situation,” said Martin Cetron, M.D., Director of CDC’s Division of Global Migration and Quarantine.
Based on current information, the risk from 2019-nCoV to the American public is presently deemed to be low. Nevertheless, CDC is taking proactive preparedness precautions.
The outbreak in Wuhan, China has been linked to a large seafood and animal market, suggesting a possible zoonotic origin to the outbreak. There are ongoing investigations to learn more.
Entry screening is part of a layered approach used with other public health measures already in place to detect arriving travelers who are sick (such as detection and reporting of ill travelers by airlines during travel and referral of ill travelers arriving at a US port of entry by CBP) to slow and reduce the spread of any disease into the United States.
Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats.
Rarely, animal coronaviruses can evolve and infect people and then spread between people such as has been seen with MERS and SARS. Past MERS and SARS outbreaks have been complex, requiring comprehensive public health responses.
Many of the patients in the outbreak in Wuhan, China have reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, suggesting limited person-to-person spread is occurring.
There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.
What to Expect
Access to the full genetic sequence of 2019-nCoV will help identify infections with this virus going forward.
The CDC says more cases may be identified in the coming days.
“Given what has occurred previously with MERS and SARS, it’s likely that some limited person-to-person spread will continue to occur,” the CDC says.
If you have information to report or questions about the coronavirus, the CDC recommends you contact your local health department. The CDC lists the Kane County contact information as follows:
Kane County Health Department
- 1240 N Highland Ave., Aurora
- Phone: (630) 444-3077
- Email Department
- Visit Website
SOURCE: CDC news release
Public Health Screening to Begin at 3 U.S. Airports for 2019 Novel Coronavirus (“2019-nCoV”)
Embargoed Until: Friday, January 17, 2020, 2:00 p.m. ET
Contact: Media Relations
(404) 639-3286
In response to an outbreak in China caused by a novel coronavirus that al to Thailand and Japan.
have implemented enhanced health screenings to detect ill travelers traveling to the United States on direct or connecting flights from Wuhan, China. This activity is in response to an outbreak in China caused by a novel (new) coronavirus (2019 nCoV), with exported cases to Thailand and Japan.
Starting January 17, 2020, travelers from Wuhan to the United States will undergo entry screening for symptoms associated with 2019-nCoV at three U.S. airports that receive most of the travelers from Wuhan, China: San Francisco (SFO), New York (JFK), and Los Angeles (LAX) airports.
“To further protect the health of the American public during the emergence of this novel coronavirus, CDC is beginning entry screening at three ports of entry. Investigations into this novel coronavirus are ongoing and we are monitoring and responding to this evolving situation,” said Martin Cetron, M.D., Director of CDC’s Division of Global Migration and Quarantine.
Based on current information, the risk from 2019-nCoV to the American public is currently deemed to be low. Nevertheless, CDC is taking proactive preparedness precautions.
Entry screening is part of a layered approach used with other public health measures already in place to detect arriving travelers who are sick (such as detection and reporting of ill travelers by airlines during travel and referral of ill travelers arriving at a US port of entry by CBP) to slow and reduce the spread of any disease into the United States.
CDC is deploying about 100 additional staff to the three airports (SFO, JFK, and LAX) to supplement existing staff at CDC quarantine stations located at those airports.
CDC is actively monitoring this situation for pertinent information about the source of outbreak, and risk for further spread through person-to-person or animal-to-person transmission. CDC may adjust screening procedures and other response activities as this outbreak investigation continues and more is learned about the newly emerging virus. Entry screening alone is not a guarantee against the possible importation of this new virus but is an important public health tool during periods of uncertainty and part of a multilayered government response strategy. As new information emerges, CDC will reassess entry screening measures and could scale activities up or down accordingly.
On Jan. 11, 2020, CDC updated a Level 1 Travel Health Notice (“practice usual precautions”) for travelers to Wuhan City and an updated Health Alert to health care professionals and public health partners with new and updated guidance is forthcoming.
China health officials report that most of the patients infected with 2019-nCoV have had exposure to a large market where live animals were present, suggesting this is a novel virus that has jumped the species barrier to infect people. Chinese authorities additionally report that several hundred health care workers caring for outbreak patients are being monitored and no spread of this virus from patients to health care workers has been seen. They report no sustained spread of this virus in the community, however there are indications that some limited person-to-person spread may have occurred. CDC is responding to this outbreak out of an abundance of caution, ready to detect people infected with 2019-CoV.
For the latest information on the outbreak, visit CDC’s Novel Coronavirus 2019 website.
===
he Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. Chinese authorities first identified the new coronavirus, which has resulted in about 200 confirmed human infections in China with three deaths reportedexternal icon. A number of countries, including the United States, are actively screening incoming travelers from Wuhan and exported cases have been confirmed in Thailand,external icon Japanexternal icon, and South Koreaexternal icon.
Chinese health authorities posted the full genome of the so-called “2019 novel coronavirus” or “2019-nCoV” in GenBankexternal icon, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAIDexternal icon) portal.
Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals, including camels, cats and bats. Rarely, animal coronaviruses can evolve and infect people and then spread between people such as has been seen with MERS and SARS. Past MERS and SARS outbreaks have been complex, requiring comprehensive public health responses.
Many of the patients in the outbreak in Wuhan, China have reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, suggesting limited person-to-person spread is occurring.
There are ongoing investigations to learn more. This is a rapidly evolving situation and information will be updated as it becomes available.
Risk Assessment
Outbreaks of novel virus infections among people are always of public health concern. The risk from these outbreaks depends on characteristics of the virus, including whether and how well it spreads between people, the severity of resulting illness, and the medical or other measures available to control the impact of the virus (for example, vaccine or treatment medications).
There is much more to learn about how the 2019-nCoV virus spreads, severity of associated illness, and other features of the virus. Investigations are ongoing. Based on current information, however, the immediate health risk from 2019-nCoV to the general American public is deemed to be low at this time. Nevertheless, CDC is taking proactive preparedness precautions.
What to Expect
Access to the full genetic sequence of 2019-nCoV will help identify infections with this virus going forward. More cases may be identified in the coming days, including more in countries outside China, and possibly in the United States. Given what has occurred previously with MERS and SARS, it’s likely that some limited person-to-person spread will continue to occur.
CDC Response
- CDC is closely monitoring this situation and is working with WHO.
- CDC established a 2019-nCoV Incident Management Structure on January 7, 2020.
- CDC has updated its interim travel health notice for this destination to provide information to people who may be traveling to Wuhan City and who may get sick.
- CDC began entry screening of passengers on direct and connecting flights from Wuhan China to the three main ports of entry in the United States on January 17, 2020.
- CDC issued an updated interim Health Alert Notice (HAN) Advisory to inform state and local health departments and health care providers about this outbreak on January 17, 2020.
- CDC has developed a Reverse Transcription-Polymerase Chain Reaction (RT-PCR) test that can diagnose 2019-nCoV. Currently, testing for this virus must take place at CDC, but in the coming days and weeks, CDC will share these tests with domestic and international partners through the agency’s International Reagent Resourceexternal icon.
Other Available Resources
The following resources are available with information on 2019-nCoV
- CDC Travelers’ Health: Novel Coronavirus in China
- CDC Health Alert Network Advisory Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China
- CDC Health Alert Network Advisory information for state and local health departments and health care providers
- CDC Information on Coronaviruses
- World Health Organization, Coronavirusexternal icon
Page last reviewed: January 20, 2020